<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="749e42fb-2fe0-45dd-9268-b43bb3f4081c"><labelDrug name="Tracleer"><Normalization><mmtx cui="C1101331" preferredWord="Tracleer" semType="phsu, orch"/></Normalization></labelDrug><generic name="bosentan"/><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1" text="Drug Label for drug brand Tracleer, containing bosentan." type="negative"><entity charOffset="26:34" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="Drug Label for drug brand Tracleer," preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Tracleer," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="47:55" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.2" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="bosentan." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.1.e.2"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.4" text="T.A.P. is a component of the Tracleer Risk Evaluation and Mitigation Strategy (REMS). " type="negative"><entity charOffset="0:6" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.4.e.0" text="t.a.p." type="Biomedical_Entity"><Normalization><mmtx cui="C2728259" phraseText="T.A.P." preferredWord="Program" semType="phsu"/><RxNorm RxCui="214909"/></Normalization></entity><entity charOffset="29:37" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.4.e.1" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="a component of the Tracleer Risk Evaluation and Mitigation Strategy (REMS)." preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.4.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.4.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.13" text="This case reinforces the importance of strict adherence to the monthly monitoring schedule for the duration of treatment and the treatment algorithm, which includes stopping Tracleer with a rise of aminotransferases accompanied by signs or symptoms of liver dysfunction see Dosage and Administration (2.2)." type="negative"><entity charOffset="174:182" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.13.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="stopping Tracleer with a rise of aminotransferases" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="165:173" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.13.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="stopping Tracleer with a rise of aminotransferases" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.13.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.13.e.0"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21" text="Throughout treatment and for one month after stopping Tracleer, females of childbearing potential must use two reliable methods of contraception unless the patient has a tubal sterilization or Copper T 380A IUD or LNg 20 IUS inserted, in which case no other contraception is needed. " type="negative"><entity charOffset="54:62" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="after stopping Tracleer," preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="193:199" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.1" text="copper" type="Biomedical_Entity"><Normalization><mmtx cui="C0009968" phraseText="Copper T 380A IUD" preferredWord="Copper" semType="bacs, phsu, elii"/><RxNorm RxCui="2837"/></Normalization></entity><entity charOffset="45:53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.2" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping Tracleer," preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.21.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22" text="Hormonal contraceptives, including oral, injectable, transdermal, and implantable contraceptives should not be used as the sole means of contraception because these may not be effective in patients receiving Tracleer see Drug Interactions (7.2). " type="negative"><entity charOffset="9:23" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.0" text="contraceptives" type="Biomedical_Entity"><Normalization><mmtx cui="C0009871" phraseText="Hormonal contraceptives," preferredWord="Contraceptive Agents" semType="phsu"/><RxNorm RxCui="2815"/></Normalization></entity><entity charOffset="208:216" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.1" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="82:96" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.2" text="contraceptives" type="Biomedical_Entity"><Normalization><mmtx cui="C0009871" phraseText="implantable contraceptives" preferredWord="Contraceptive Agents" semType="phsu"/><RxNorm RxCui="2815"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.22.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.32" text="&lt;item&gt;To prevent pregnancy, females of childbearing potential must use two reliable forms of contraception during treatment and for one month after stopping Tracleer (4.1, 8.1)." type="negative"><entity charOffset="157:165" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.32.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="after stopping Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="148:156" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.32.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping Tracleer" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.32.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.32.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36" lineNumber="43" text="&lt;item&gt;Use with Cyclosporine A (4.2)" type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.34" Text="CONTRAINDICATIONS"/><anaphoraEntity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.1" text="Use" type="Expression"/><antecedentEntity charOffset="0:17" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.34.e.0" text="CONTRAINDICATIONS" type="SPAN"/></anaphoraRelation><entity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.3" text="Use" type="Caution_Interaction"/><entity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.4" text="Use" type="SPAN"/><entity charOffset="15:29" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.5" text="Cyclosporine A" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="&gt;Use with Cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.3"><relations><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.5"/></relation><relation type="hasObject"><labelDrug text="Tracleer"/><normalization><mmtx><preferredWord>Tracleer</preferredWord><phraseText>concomitant use of Tracleer</phraseText><cuiCode>C1101331</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.36.e.5"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37" lineNumber="45" text="&lt;item&gt;Use with Glyburide (4.3)" type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.34" Text="CONTRAINDICATIONS"/><anaphoraEntity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.1" text="Use" type="Expression"/><antecedentEntity charOffset="0:17" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.34.e.0" text="CONTRAINDICATIONS" type="SPAN"/></anaphoraRelation><entity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.3" text="Use" type="Caution_Interaction"/><entity charOffset="6:9" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.4" text="Use" type="SPAN"/><entity charOffset="15:24" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.5" text="Glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="&gt;Use with Glyburide" preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.3"><relations><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.5"/></relation><relation type="hasObject"><labelDrug text="Tracleer"/><normalization><mmtx><preferredWord>Tracleer</preferredWord><phraseText>concomitant use of Tracleer</phraseText><cuiCode>C1101331</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.37.e.5"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.41" text="To prevent pregnancy, females of childbearing potential must use two reliable forms of contraception during treatment and for one month after stopping Tracleer. see Boxed Warning, Warnings and Precautions (5.2), Drug Interactions (7.2), Use in Specific Populations (8.1)." type="negative"><entity charOffset="151:159" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.41.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="after stopping Tracleer." preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="142:150" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.41.e.1" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="after stopping Tracleer." preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.41.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.41.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43" lineNumber="58" text="Coadministration of cyclosporine A and bosentan resulted in markedly increased plasma concentrations of bosentan. " type="regular"><entity charOffset="69:100" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.1" text="increased plasma concentrations" type="Increase_Interaction"/><entity charOffset="20:34" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.2" text="cyclosporine A" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="Coadministration of cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="104:112" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="resulted in markedly increased plasma concentrations of bosentan." preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="resulted in markedly increased plasma concentrations of bosentan." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.43.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44" lineNumber="58" text="Therefore, concomitant use of Tracleer and cyclosporine A is contraindicated see Drug Interactions (7.3)." type="regular"><entity charOffset="61:76" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="30:38" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="concomitant use of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="61:76" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.3" text="contraindicated" type="SPAN"/><entity charOffset="43:57" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.4" text="cyclosporine A" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.2"/></relation><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.4" severity="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.44.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46" lineNumber="62" text="An increased risk of liver enzyme elevations was observed in patients receiving glyburide concomitantly with bosentan. " type="regular"><entity charOffset="21:44" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.1" text="liver enzyme elevations" type="Specific_Interaction"/><entity charOffset="80:89" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.2" text="glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="glyburide concomitantly with bosentan." preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="109:117" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="glyburide concomitantly with bosentan." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.46.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47" lineNumber="62" text="Therefore coadministration of glyburide and Tracleer is contraindicated see Drug Interactions (7.4)." type="regular"><entity charOffset="56:71" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="56:71" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.2" text="contraindicated" type="SPAN"/><entity charOffset="30:39" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.3" text="glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="Therefore coadministration of glyburide" preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="44:52" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.4" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.4" severity="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.47.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.49" text="Tracleer is contraindicated in patients who are hypersensitive to bosentan or any component of the product. " type="negative"><entity charOffset="0:8" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.49.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="66:74" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.49.e.1" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="hypersensitive to bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.49.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.49.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.80" text="Peripheral edema is a known clinical consequence of PAH and worsening PAH and is also a known effect of Tracleer and other endothelin receptor antagonists. " type="negative"><entity charOffset="104:112" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.80.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="a known effect of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="123:154" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.80.e.1" text="endothelin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C3537018" phraseText="other endothelin receptor antagonists." preferredWord="Endothelin Receptor Antagonist [EPC]" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.80.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.80.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.89" text="Preclinical data also suggest that Tracleer, like other endothelin receptor antagonists, may have an adverse effect on spermatogenesis see Adverse Reactions (6.1), Nonclinical Toxicology (13.1)." type="negative"><entity charOffset="35:43" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.89.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="that Tracleer," preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="56:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.89.e.1" text="endothelin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C1134681" phraseText="like other endothelin receptor antagonists," preferredWord="Endothelin receptor antagonist" semType="phsu"/><RxNorm RxCui="40080"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.89.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.89.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97" lineNumber="137" text="&lt;item&gt;Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)." type="regular"><anaphoraRelation><anaphoraEntity charOffset="54:67" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.3" text="contraceptive" type="Expression"/><antecedentEntity charOffset="6-29" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.7" text="Hormonal contraceptives" type="Drug_Class"/></anaphoraRelation><entity charOffset="44:53|68:76" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.1" text="decreases exposure" type="Decrease_Interaction"/><entity charOffset="31:39" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer use" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="81:102" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.5" text="reduces effectiveness" type="Decrease_Interaction"/><entity charOffset="6:29" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.7" text="Hormonal contraceptives" type="Drug_Class"><Normalization><mmtx cui="C0009871" phraseText="&gt;Hormonal contraceptives" preferredWord="Contraceptive Agents" semType="phsu"/><RxNorm RxCui="1430744"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.ddi.2"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98" lineNumber="139" text="&lt;item&gt;Simvastatin and other CYP3A-metabolized statins: Combination use decreases statin exposure and may reduce efficacy (7.6)." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="81:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.2" text="statin" type="Expression"/><antecedentEntity charOffset="6-17" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.6" text="Simvastatin" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="81:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.2" text="statin" type="Expression"/><antecedentEntity charOffset="28-53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.8" text="CYP3A-metabolized statins" type="Drug_Class"/></anaphoraRelation><entity charOffset="71:80|88:96" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.1" text="decreases exposure" type="Decrease_Interaction"/><entity charOffset="105:120" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.4" text="reduce efficacy" type="Decrease_Interaction"/><entity charOffset="6:17" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.6" text="Simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="&gt;Simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="28:53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.8" text="CYP3A-metabolized statins" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="other CYP3A-metabolized statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="24348"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97" text="&lt;item&gt;Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.ddi.2"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97" text="&lt;item&gt;Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.97.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.98.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99" lineNumber="141" text="&lt;item&gt;Rifampin: Alters bosentan exposure. " type="regular"><entity charOffset="16:22|32:40" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.1" text="Alters exposure" type="Specific_Interaction"/><entity charOffset="6:14" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.2" text="Rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="&gt;Rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="bosentan exposure." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.100" lineNumber="141" text="Monitor hepatic function weekly for 4 weeks, followed by normal monitoring (7.7)." type="irregular"><entity charOffset="0:7" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.100.e.1" text="Monitor" type="Caution_Interaction"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.100.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.100.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99" text="&lt;item&gt;Rifampin: Alters bosentan exposure. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99" text="&lt;item&gt;Rifampin: Alters bosentan exposure. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.99.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.103" text="Inhibition of these enzymes may increase the plasma concentration of bosentan (see ketoconazole). " type="negative"><entity charOffset="69:77" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.103.e.0" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="the plasma concentration of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="83:95" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.103.e.1" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole" preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.103.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.103.e.1"/></sentence><sentence biomedicalEntities="13" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104" lineNumber="148" text="Concomitant administration of both a CYP2C9 inhibitor (such as fluconazole or amiodarone) and a strong CYP3A inhibitor (e.g., ketoconazole, itraconazole) or a moderate CYP3A inhibitor (e.g., amprenavir, erythromycin, fluconazole, diltiazem) with Tracleer will likely lead to large increases in plasma concentrations of bosentan. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="319:327" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3" text="bosentan" type="Drug"/><antecedentEntity charOffset="246-254" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.7" text="Tracleer" type="Drug"/></anaphoraRelation><entity charOffset="281:315" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.1" text="increases in plasma concentrations" type="Increase_Interaction"/><entity charOffset="37:53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2" text="CYP2C9 inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="687278"/></Normalization></entity><entity charOffset="319:327" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="of bosentan." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="96:118" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4" text="strong CYP3A inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="159:183" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5" text="moderate CYP3A inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><entity charOffset="246:254" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.7" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="with Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="63:74" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.9" text="fluconazole" type="Drug"><Normalization><mmtx cui="C0016277" phraseText="such as fluconazole" preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.11" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="126:138" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.13" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="140:152" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.15" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="191:201" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.17" text="amprenavir" type="Drug"><Normalization><mmtx cui="C0754188" phraseText="amprenavir," preferredWord="Amprenavir" semType="phsu, orch"/><RxNorm RxCui="228656"/></Normalization></entity><entity charOffset="203:215" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.19" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="217:228" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.21" text="fluconazole" type="Drug"><Normalization><mmtx cui="C0016277" phraseText="fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="230:239" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.23" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.9" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.11" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.13" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.15" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.17" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.19" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.21" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.23" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.1" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.104.e.5"/></sentence><sentence biomedicalEntities="4" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105" lineNumber="148" text="Coadministration of such combinations of a CYP2C9 inhibitor plus a strong or moderate CYP3A inhibitor with Tracleer is not recommended." type="regular"><entity charOffset="119:134" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.1" text="not recommended" type="Caution_Interaction"/><entity charOffset="77:101" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.2" text="moderate CYP3A inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="855444"/></Normalization></entity><entity charOffset="43:59" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.3" text="CYP2C9 inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="687278"/></Normalization></entity><entity charOffset="107:115" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.4" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="moderate CYP3A inhibitor with Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="67:73|86:101" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.5" text="strong CYP3A inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.5" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.5" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.105.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107" lineNumber="149" text="Consequently plasma concentrations of drugs metabolized by these two isozymes will be decreased when Tracleer is coadministered. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.106" Text="Bosentan is an inducer of CYP3A and CYP2C9. "/><anaphoraEntity charOffset="65:77" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.5" text="two isozymes" type="Expression"/><antecedentEntity charOffset="26:42" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.106.e.0" text="CYP3A and CYP2C9" type="Substance"/></anaphoraRelation><entity charOffset="13:34|86:95" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.1" text="plasma concentrations decreased" type="Decrease_Interaction"/><entity charOffset="101:109" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="38:77" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.3" text="drugs metabolized by these two isozymes" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Consequently plasma concentrations of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0013227" phraseText="Consequently plasma concentrations of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.107.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111" lineNumber="153" text="Hormonal contraceptives, including oral, injectable, transdermal, and implantable forms, may not be reliable when Tracleer is coadministered. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="82:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.4" text="forms" type="Expression"/><antecedentEntity charOffset="0-23" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.2" text="Hormonal contraceptives" type="Drug_Class"/></anaphoraRelation><entity charOffset="93:108" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.1" text="not be reliable" type="Decrease_Interaction"/><entity charOffset="0:23" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.2" text="Hormonal contraceptives" type="Drug_Class"><Normalization><mmtx cui="C0009871" phraseText="Hormonal contraceptives," preferredWord="Contraceptive Agents" semType="phsu"/><RxNorm RxCui="1430744"/></Normalization></entity><entity charOffset="114:122" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.3" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="35:39|82:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.6" text="oral forms" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="41:51|82:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.7" text="injectable forms" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="53:64|82:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.8" text="transdermal forms" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="70:81|82:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.9" text="implantable forms" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><classClassMembership drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.6"/><classClassMembership drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.8"/><classClassMembership drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.9"/><classClassMembership drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.7"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.111.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112" lineNumber="153" text="Females should practice additional methods of contraception and not rely on hormonal contraception alone when taking Tracleer see Boxed Warning, Contraindications (4.1)." type="regular"><entity charOffset="64:72" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.1" text="not rely" type="Caution_Interaction"/><entity charOffset="76:98" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.2" text="hormonal contraception" type="Drug_Class"><Normalization><RxNorm RxCui="1430744"/></Normalization></entity><entity charOffset="117:125" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.3" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="taking Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.112.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113" lineNumber="154" text="An interaction study demonstrated that coadministration of bosentan and a combination oral hormonal contraceptive produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="162:179" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.4" text="ethinyl estradiol" type="Drug"/><antecedentEntity charOffset="74-113" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.6" text="combination oral hormonal contraceptive" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="144:157" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.3" text="norethindrone" type="Drug"/><antecedentEntity charOffset="74-113" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.6" text="combination oral hormonal contraceptive" type="Drug"/></anaphoraRelation><entity charOffset="131:143|180:186" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.1" text="decreases of levels" type="Decrease_Interaction"/><entity charOffset="59:67" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.2" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="that coadministration of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="144:157" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.3" text="norethindrone" type="Drug"><Normalization><mmtx cui="C0028356" phraseText="a combination oral hormonal contraceptive produced average decreases of norethindrone" preferredWord="Norethindrone" semType="strd, phsu, horm"/><RxNorm RxCui="7514"/></Normalization></entity><entity charOffset="162:179" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.4" text="ethinyl estradiol" type="Drug"><Normalization><mmtx cui="C0015011" phraseText="ethinyl estradiol levels of 14%" preferredWord="Ethinyl Estradiol" semType="strd, phsu, horm"/><RxNorm RxCui="4124"/></Normalization></entity><entity charOffset="74:113" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.6" text="combination oral hormonal contraceptive" type="Drug"><Normalization><mmtx cui="C1627340" phraseText="a combination oral hormonal contraceptive produced average decreases of norethindrone" preferredWord="Combination oral contraceptive agent" semType="strd, phsu, horm"/><RxNorm RxCui="1429321"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.114" lineNumber="154" text="However, decreases in exposure were as much as 56% and 66%, respectively, in individual subjects." type="irregular"><entity charOffset="9:30" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.114.e.1" text="decreases in exposure" type="Decrease_Interaction"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.114.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.114.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113" text="An interaction study demonstrated that coadministration of bosentan and a combination oral hormonal contraceptive produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113" text="An interaction study demonstrated that coadministration of bosentan and a combination oral hormonal contraceptive produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.3"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113" text="An interaction study demonstrated that coadministration of bosentan and a combination oral hormonal contraceptive produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.113.e.4"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116" lineNumber="158" text="The concomitant administration of Tracleer and cyclosporine A is contraindicated see Contraindications (4.2)." type="regular"><entity charOffset="65:80" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="34:42" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="The concomitant administration of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="47:63" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.3" text="cyclosporine A i" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="65:80" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.4" text="contraindicated" type="SPAN"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.3"/></relation><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.3" severity="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117" lineNumber="159" text="During the first day of concomitant administration, trough concentrations of bosentan were increased by about 30-fold. " type="irregular"><entity charOffset="52:73|91:102" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117.e.1" text="trough concentrations increased b" type="Increase_Interaction"/><entity charOffset="77:85" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117.e.2" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="trough concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116" text="The concomitant administration of Tracleer and cyclosporine A is contraindicated see Contraindications (4.2)."><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.116.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.117.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118" text="The mechanism of this interaction is most likely inhibition of transport protein-mediated uptake of bosentan into hepatocytes by cyclosporine. " type="negative"><entity charOffset="129:141" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.0" text="cyclosporine" type="Biomedical_Entity"><Normalization><mmtx cui="C0010592" phraseText="by cyclosporine." preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="81:89" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="most likely inhibition of transport protein-mediated uptake of bosentan" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="100:108" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.2" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="most likely inhibition of transport protein-mediated uptake of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.118.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119" lineNumber="159" text="Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A. " type="regular"><entity charOffset="0:12|22:43|62:68" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.1" text="Steady-state plasma concentrations higher" type="Increase_Interaction"/><entity charOffset="92:106" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.2" text="cyclosporine A" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="of cyclosporine A." preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="13:21" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="Steady-state bosentan plasma concentrations" preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="Steady-state bosentan plasma concentrations" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.119.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120" lineNumber="159" text="Coadministration of bosentan decreased the plasma concentrations of cyclosporine A (a CYP3A substrate) by approximately 50%." type="regular"><entity charOffset="20:28" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.0" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="Coadministration of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="29:64" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.2" text="decreased the plasma concentrations" type="Decrease_Interaction"/><entity charOffset="68:82" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.3" text="cyclosporine A" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="the plasma concentrations of cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><mmtx cui="C0010592" phraseText="the plasma concentrations of cyclosporine A" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="86:101" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.5" text="CYP3A substrate" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.3" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.5"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122" lineNumber="163" text="An increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with glyburide. " type="irregular"><entity charOffset="21:53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.e.1" text="elevated liver aminotransferases" type="Specific_Interaction"/><entity charOffset="114:123" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.e.2" text="glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="concomitant therapy with glyburide." preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120" text="Coadministration of bosentan decreased the plasma concentrations of cyclosporine A (a CYP3A substrate) by approximately 50%."><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.120.e.0"/></ellipsisSentence><middleSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.121" text="7.4 Glyburide"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.122.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123" lineNumber="163" text="Therefore, the concomitant administration of Tracleer and glyburide is contraindicated, and alternative hypoglycemic agents should be considered see Contraindications (4.3)." type="regular"><entity charOffset="71:86" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="71:86" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.2" text="contraindicated" type="SPAN"/><entity charOffset="58:67" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.3" text="glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="glyburide" preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="45:53" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.4" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="the concomitant administration of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.3" severity="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.123.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124" lineNumber="164" text="Coadministration of bosentan decreased the plasma concentrations of glyburide by approximately 40%. " type="regular"><entity charOffset="29:64" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.1" text="decreased the plasma concentrations" type="Decrease_Interaction"/><entity charOffset="20:28" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.2" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="Coadministration of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="68:77" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.3" text="glyburide" type="Drug"><Normalization><mmtx cui="C0017628" phraseText="the plasma concentrations of glyburide" preferredWord="Glyburide" semType="phsu, orch"/><mmtx cui="C0017628" phraseText="the plasma concentrations of glyburide" preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125" lineNumber="164" text="The plasma concentrations of bosentan were also decreased by approximately 30%. " type="irregular"><entity charOffset="4:25|48:57" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125.e.1" text="plasma concentrations decreased" type="Decrease_Interaction"/><entity charOffset="29:37" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125.e.2" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="The plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="The plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124" text="Coadministration of bosentan decreased the plasma concentrations of glyburide by approximately 40%. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.124.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.125.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126" lineNumber="164" text="Tracleer is also expected to reduce plasma concentrations of other oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A. " type="regular"><entity charOffset="29:57" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.1" text="reduce plasma concentrations" type="Decrease_Interaction"/><entity charOffset="0:8" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="67:145" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.3" text="oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="plasma concentrations of other oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><mmtx cui="C0359086" phraseText="plasma concentrations of other oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.127" lineNumber="164" text="The possibility of worsened glucose control in patients using these agents should be considered." type="irregular"><entity charOffset="19:43" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.127.e.1" text="worsened glucose control" type="Specific_Interaction"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.127.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.127.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126" text="Tracleer is also expected to reduce plasma concentrations of other oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.3"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126" text="Tracleer is also expected to reduce plasma concentrations of other oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.126.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.128" text="7.5 Lopinavir/Ritonavir or Other Ritonavir-containing HIV Regimens" type="negative"><entity charOffset="33:42" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.128.e.0" text="ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0292818" phraseText="Other Ritonavir-containing HIV Regimens" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="4:23" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.128.e.1" text="lopinavir/ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0939237" phraseText="7.5 Lopinavir/Ritonavir" preferredWord="lopinavir / Ritonavir" semType="phsu, orch"/><RxNorm RxCui="284640"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.128.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.128.e.0"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.131" text="However, the impact of ritonavir on the pharmacokinetics of bosentan may largely result from its effect on OATP." type="negative"><entity charOffset="60:68" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.131.e.0" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="23:32" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.131.e.1" text="ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0292818" phraseText="the impact of ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.131.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.131.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132" lineNumber="169" text="In normal volunteers, coadministration of Tracleer 125 mg twice daily and lopinavir/ritonavir 400/100 mg twice daily increased the trough concentrations of bosentan on Days 4 and 10 approximately 48-fold and 5-fold, respectively, compared with those measured after Tracleer administered alone. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="156:164" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.3" text="bosentan" type="Drug"/><antecedentEntity charOffset="42-50" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.5" text="Tracleer" type="Drug"/></anaphoraRelation><entity charOffset="117:152" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.1" text="increased the trough concentrations" type="Increase_Interaction"/><entity charOffset="74:93" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.2" text="lopinavir/ritonavir" type="Drug"><Normalization><mmtx cui="C1967929" phraseText="lopinavir/ritonavir 400/100 mg twice daily" preferredWord="lopinavir 100 MG" semType="clnd"/><mmtx cui="C0292818" phraseText="lopinavir/ritonavir 400/100 mg twice daily" preferredWord="Ritonavir" semType="phsu, orch"/><mmtx cui="C0674432" phraseText="lopinavir/ritonavir 400/100 mg twice daily" preferredWord="lopinavir" semType="phsu, orch"/><RxNorm RxCui="284640"/></Normalization></entity><entity charOffset="156:164" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="the trough concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="42:50" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.5" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="coadministration of Tracleer 125 mg twice daily" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.132.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133" lineNumber="169" text="Therefore, adjust the dose of Tracleer when initiating lopinavir/ritonavir see Dosage and Administration (2.4." type="regular"><entity charOffset="11:26" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.1" text="adjust the dose" type="Caution_Interaction"/><entity charOffset="30:38" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="the dose of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="55:74" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.3" text="lopinavir/ritonavir" type="Drug"><Normalization><mmtx cui="C0939237" phraseText="initiating lopinavir/ritonavir" preferredWord="lopinavir / Ritonavir" semType="phsu, orch"/><RxNorm RxCui="284640"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.133.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134" text="Coadministration of bosentan 125 mg twice daily had no substantial impact on the pharmacokinetics of lopinavir/ritonavir 400/100 mg twice daily." type="negative"><entity charOffset="20:35" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.0" text="bosentan 125 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1168564" phraseText="Coadministration of bosentan 125 mg twice daily" preferredWord="bosentan 125 MG" semType="clnd"/><RxNorm RxCui="498193"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.1" text="lopinavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0674432" phraseText="of lopinavir/ritonavir 400/100 mg twice daily." preferredWord="lopinavir" semType="phsu, orch"/><RxNorm RxCui="195088"/></Normalization></entity><entity charOffset="111:120" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.2" text="ritonavir" type="Biomedical_Entity"><Normalization><mmtx cui="C0292818" phraseText="of lopinavir/ritonavir 400/100 mg twice daily." preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="101:131" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.3" text="lopinavir 100 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1967929" phraseText="of lopinavir/ritonavir 400/100 mg twice daily." preferredWord="lopinavir 100 MG" semType="clnd"/><RxNorm RxCui="195088"/></Normalization></entity><entity charOffset="111:131" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.4" text="ritonavir 100 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0992889" phraseText="of lopinavir/ritonavir 400/100 mg twice daily." preferredWord="Ritonavir 100 MG" semType="clnd"/><RxNorm RxCui="85762"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.3"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.4"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.4"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.134.e.4"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.135" text="7.6 Simvastatin and Other Statins" type="negative"><entity charOffset="4:15" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.135.e.0" text="simvastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0074554" phraseText="7.6 Simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.135.e.1" text="statins" type="Biomedical_Entity"><Normalization><mmtx cui="C0360714" phraseText="Other Statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="108229"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.135.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.135.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136" lineNumber="174" text="Coadministration of bosentan decreased the plasma concentrations of simvastatin (a CYP3A substrate), and its active -hydroxy acid metabolite, by approximately 50%. " type="regular"><entity charOffset="83:98" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.1" text="CYP3A substrate" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="68:79" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the plasma concentrations of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><mmtx cui="C0074554" phraseText="the plasma concentrations of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="29:64" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.4" text="decreased the plasma concentrations" type="Decrease_Interaction"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.2" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.1"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.4"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.136.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138" lineNumber="174" text="Tracleer is also expected to reduce plasma concentrations of other statins that are significantly metabolized by CYP3A, such as lovastatin and atorvastatin. " type="regular"><entity charOffset="29:57" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.1" text="reduce plasma concentrations" type="Decrease_Interaction"/><entity charOffset="67:118" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2" text="statins that are significantly metabolized by CYP3A" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="plasma concentrations of other statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><mmtx cui="C0360714" phraseText="plasma concentrations of other statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="108229"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.3" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="128:138" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.5" text="lovastatin" type="Drug"><Normalization><mmtx cui="C0024027" phraseText="such as lovastatin" preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><entity charOffset="143:155" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.7" text="atorvastatin" type="Drug"><Normalization><mmtx cui="C0286651" phraseText="atorvastatin." preferredWord="atorvastatin" semType="phsu, orch"/><RxNorm RxCui="83367"/></Normalization></entity><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.5" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.7" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139" lineNumber="174" text="The possibility of reduced statin efficacy should be considered. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138" Text="Tracleer is also expected to reduce plasma concentrations of other statins that are significantly metabolized by CYP3A, such as lovastatin and atorvastatin. "/><anaphoraEntity charOffset="27:33" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139.e.2" text="statin" type="Expression"/><antecedentEntity charOffset="67:118" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.2" text="statins that are significantly metabolized by CYP3A" type="Drug_Class"/></anaphoraRelation><entity charOffset="19:26|34:42" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139.e.1" text="reduced efficacy" type="Decrease_Interaction"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.139.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138" text="Tracleer is also expected to reduce plasma concentrations of other statins that are significantly metabolized by CYP3A, such as lovastatin and atorvastatin. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.138.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140" lineNumber="174" text="Patients using CYP3A-metabolized statins should have cholesterol levels monitored after Tracleer is initiated to see whether the statin dose needs adjustment." type="regular"><anaphoraRelation><anaphoraEntity charOffset="129:135" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.3" text="statin" type="Expression"/><antecedentEntity charOffset="15-40" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.5" text="CYP3A-metabolized statins" type="Drug_Class"/></anaphoraRelation><entity charOffset="136:157" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.1" text="dose needs adjustment" type="Caution_Interaction"/><entity charOffset="88:96" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="monitored after Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="15:40" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.5" text="CYP3A-metabolized statins" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="CYP3A-metabolized statins" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="24348"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.140.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142" lineNumber="178" text="Coadministration of bosentan and rifampin in normal volunteers resulted in a mean 6-fold increase in bosentan trough levels after the first concomitant dose (likely due to inhibition of OATP by rifampin), but about a 60% decrease in bosentan levels at steady-state. " type="regular"><entity charOffset="89:100|110:123" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.1" text="increase in trough levels" type="Increase_Interaction"/><entity charOffset="33:41" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.2" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin in normal volunteers" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="101:109" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="in bosentan trough levels" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="221:232|242:264" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.5" text="decrease in levels at steady-state" type="Decrease_Interaction"/><entity charOffset="233:241" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.6" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="in bosentan levels" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.ddi.2"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.5"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.3" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.6" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.142.e.5" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143" text="The effect of Tracleer on rifampin levels has not been assessed. " type="negative"><entity charOffset="14:22" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="The effect of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="26:34" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.1" text="rifampin" type="Biomedical_Entity"><Normalization><mmtx cui="C0035608" phraseText="on rifampin levels" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.144" lineNumber="178" text="When consideration of the potential benefits, and known and unknown risks leads to concomitant use, measure serum aminotransferases weekly for the first 4 weeks before reverting to normal monitoring." type="irregular"><entity charOffset="100:107" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.144.e.1" text="measure" type="Caution_Interaction"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.144.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.144.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143" text="The effect of Tracleer on rifampin levels has not been assessed. "><entity charOffset="14:22" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.0" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="The effect of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143" text="The effect of Tracleer on rifampin levels has not been assessed. "><entity charOffset="26:34" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.143.e.1" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="on rifampin levels" preferredWord="Rifampin" semType="orch, antb"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.146" text="Coadministration of tacrolimus and Tracleer has not been studied in humans. " type="negative"><entity charOffset="20:30" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.146.e.0" text="tacrolimus" type="Biomedical_Entity"><Normalization><mmtx cui="C0085149" phraseText="Coadministration of tacrolimus" preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="35:43" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.146.e.1" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.146.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.146.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147" lineNumber="182" text="Coadministration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals. " type="regular"><entity charOffset="65:96" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.1" text="increased plasma concentrations" type="Increase_Interaction"/><entity charOffset="109:119" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.2" text="in animals" type="SPAN"/><entity charOffset="20:30" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.3" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="Coadministration of tacrolimus" preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="100:108" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.4" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="resulted in markedly increased plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="resulted in markedly increased plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.1"><relations><relation type="hasEvidence"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.4" evidence="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.147.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148" lineNumber="182" text="Caution should be exercised if tacrolimus and Tracleer are used together." type="regular"><entity charOffset="0:7" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.1" text="Caution" type="Caution_Interaction"/><entity charOffset="46:54" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="31:41" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.3" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="tacrolimus" preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.148.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150" lineNumber="186" text="Coadministration of bosentan 125 mg twice daily and ketoconazole, a potent CYP3A inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold in normal volunteers. " type="regular"><entity charOffset="68:90" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.1" text="potent CYP3A inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="52:64" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.2" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="92:127" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.4" text="increased the plasma concentrations" type="Increase_Interaction"/><entity charOffset="131:139" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.5" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="the plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="the plasma concentrations of bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.2" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.1"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.4"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.5" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151" lineNumber="186" text="No dose adjustment of Tracleer is necessary, but increased effects of Tracleer should be considered." type="irregular"><entity charOffset="49:66" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151.e.1" text="increased effects" type="Increase_Interaction"/><entity charOffset="70:78" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151.e.2" text="Tracleer" type="Drug"><Normalization><mmtx cui="C1101331" phraseText="increased effects of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.151.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150" text="Coadministration of bosentan 125 mg twice daily and ketoconazole, a potent CYP3A inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold in normal volunteers. "><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.150.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153" lineNumber="190" text="Coadministration of bosentan 500 mg twice daily for 6 days in normal volunteers decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A substrate) by 29 and 38%, respectively. " type="regular"><entity charOffset="80:115" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.1" text="decreased the plasma concentrations" type="Decrease_Interaction"/><entity charOffset="160:170" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.2" text="R-warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="R-warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="20:28" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="Coadministration of bosentan 500 mg twice daily" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="124:134" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.4" text="S-warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="138:154" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.6" text="CYP2C9 substrate" type="Drug_Class"><Normalization><RxNorm RxCui="687278"/></Normalization></entity><entity charOffset="172:189" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.8" text="a CYP3A substrate" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.4" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.6"/><drugClassMembership drug="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.2" drugClass="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.8"/><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.4" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.153.e.1" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154" text="Clinical experience with concomitant administration of Tracleer and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in INR or warfarin dose (baseline vs. end of the clinical studies), and the need to change the warfarin dose during the trials due to changes in INR or due to adverse events was similar among Tracleer- and placebo-treated patients." type="negative"><entity charOffset="359:367" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.0" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="similar among Tracleer-" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="262:270" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="the warfarin dose during the trials" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="177:185" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.2" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin dose" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="55:63" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.3" text="tracleer" type="Biomedical_Entity"><Normalization><mmtx cui="C1101331" phraseText="Clinical experience with concomitant administration of Tracleer" preferredWord="Tracleer" semType="phsu, orch"/><RxNorm RxCui="323502"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.4" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin in patients" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.154.e.4"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155" text="7.11 Digoxin, Nimodipine, and Losartan" type="negative"><entity charOffset="30:38" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.0" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="Losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><entity charOffset="14:24" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.1" text="nimodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028094" phraseText="Nimodipine," preferredWord="Nimodipine" semType="phsu, orch"/><RxNorm RxCui="7426"/></Normalization></entity><entity charOffset="5:12" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.2" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="7.11 Digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.0"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.155.e.1"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156" text="Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan." type="negative"><entity charOffset="0:8" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.0" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="Bosentan" preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="145:153" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.1" text="bosentan" type="Biomedical_Entity"><Normalization><mmtx cui="C0252643" phraseText="no significant effect on plasma levels of bosentan." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="74:84" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.2" text="nimodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028094" phraseText="nimodipine," preferredWord="Nimodipine" semType="phsu, orch"/><RxNorm RxCui="7426"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="no significant pharmacokinetic interactions with digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="90:98" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.4" text="losartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0126174" phraseText="losartan" preferredWord="Losartan" semType="phsu, orch"/><RxNorm RxCui="52175"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.3"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.0" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.4"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.4" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.1"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.2"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.2" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.4"/><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.156.e.4"/></sentence><sentence biomedicalEntities="4" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158" lineNumber="198" text="In normal volunteers, coadministration of multiple doses of 125 mg twice daily bosentan and 80 mg three times daily sildenafil resulted in a reduction of sildenafil plasma concentrations by 63% and increased bosentan plasma concentrations by 50%. " type="regular"><entity charOffset="141:153|165:186" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.1" text="reduction of plasma concentrations" type="Decrease_Interaction"/><entity charOffset="154:164" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.2" text="sildenafil" type="Drug"><Normalization><mmtx cui="C0529793" phraseText="resulted in a reduction of sildenafil plasma concentrations" preferredWord="sildenafil" semType="phsu, orch"/><mmtx cui="C0529793" phraseText="resulted in a reduction of sildenafil plasma concentrations" preferredWord="sildenafil" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="79:87" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.3" text="bosentan" type="Drug"><Normalization><mmtx cui="C1168564" phraseText="coadministration of multiple doses of 125 mg twice daily bosentan" preferredWord="bosentan 125 MG" semType="clnd"/><RxNorm RxCui="75207"/></Normalization></entity><entity charOffset="198:207|217:238" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.5" text="increased plasma concentrations" type="Increase_Interaction"/><entity charOffset="116:126" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.6" text="sildenafil" type="Drug"><Normalization><mmtx cui="C0529793" phraseText="80 mg three times daily sildenafil" preferredWord="sildenafil" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="208:216" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.7" text="bosentan" type="Drug"><Normalization><mmtx cui="C0252643" phraseText="increased bosentan plasma concentrations by 50%." preferredWord="bosentan" semType="phsu, orch"/><mmtx cui="C0252643" phraseText="increased bosentan plasma concentrations by 50%." preferredWord="bosentan" semType="phsu, orch"/><RxNorm RxCui="75207"/></Normalization></entity><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.ddi.1"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.1"><relations><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.ddi.2"><interaction trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.3" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.2" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.6" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.7" trigger="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.158.e.5" type="Increase_Interaction"/></sentence><sentence id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.162" text="In a small, randomized, double-blind, placebo-controlled study, 34 patients treated with bosentan 125 mg twice daily for at least 16 weeks tolerated the addition of inhaled iloprost (up to 5 mcg 6 to 9 times per day during waking hours). " type="negative"><entity charOffset="173:181" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.162.e.0" text="iloprost" type="Biomedical_Entity"><Normalization><mmtx cui="C0079594" phraseText="the addition of inhaled iloprost" preferredWord="Iloprost" semType="eico, phsu"/><RxNorm RxCui="40138"/></Normalization></entity><entity charOffset="89:104" id="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.162.e.1" text="bosentan 125 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1168564" phraseText="treated with bosentan 125 mg twice daily" preferredWord="bosentan 125 MG" semType="clnd"/><RxNorm RxCui="498193"/></Normalization></entity><pair ddi="false" e1="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.162.e.1" e2="Dailymed.749e42fb-2fe0-45dd-9268-b43bb3f4081c.s.162.e.0"/></sentence><positiveExamples number="39"/><negativeExamples number="59"/></document>